当前位置： SCI文献检索 > PHARMACOEPIDEMIOLOGY AND DRUG SAFETY期刊下所有文献 > Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.

Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.

Abstract：

PURPOSE:To provide an up-to-date account of drug prescription during pregnancy in France from 2011 to 2014 using the permanent sample of the French national computerized healthcare database and with a focus on recommended supplementations, fetotoxic drugs and teratogenic drugs. METHODS:All pregnancies identified by the International Classification of Diseases, 10th Revision codes list in the hospitalization database, lasting more than 9 weeks of amenorrhea and whose delivery occurred between 01/01/2011 and 12/31/2014, were included. Drugs delivered between the trimester before and until the end of the pregnancy were included. Drug exposure prevalence was calculated for each year and according to pregnancy trimesters. RESULTS:The study included 28,491 pregnancies with a median number of 9 [5-13] (median [IQ range]) drugs delivered. The most prescribed drug class was antianemia (in 72.5% of exposed). The prescription rate of recommended vitamins (B9 and D) increased over the study period (+10%). Influenza vaccination also increased but remained at a low rate (1%). Exposure to fetotoxic drugs decreased as pregnancy advanced. Exposure to the main teratogenic antiepileptics was stable over the study period. Low-income pregnant women had a higher average drug consumption except for recommended vitamins. CONCLUSION:Pregnant French women are among the largest consumers of prescription medications worldwide. Overall, the dispensation trends observed in this study are in line with the recommendations of the French National College of Gynecologists and Obstetricians. Nevertheless, while being low, exposure to fetotoxic drugs, teratogenic drugs or those under safety alerts still occurred. Supplementations and vaccines in low-income pregnant women should also be increased.

journal_name

Pharmacoepidemiol Drug Saf

journal_title

Pharmacoepidemiology and drug safety

authors

Demailly R,Escolano S,Quantin C,Tubert-Bitter P,Ahmed I

doi

10.1002/pds.4265

subject

Has Abstract

pub_date

2017-09-01 00:00:00

pages

1126-1134

issue

9

eissn

1053-8569

issn

1099-1557

journal_volume

26

pub_type

杂志文章

相关文献

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY文献大全
  • Evaluation of total hip arthroplasty devices using a total joint replacement registry.

    abstract：PURPOSE:The purpose of this paper is to describe the infrastructure of the total joint replacement registry of a large integrated healthcare system's and emphasize challenges associated with orthopedic device classification and evaluation. METHODS:Using a large integrated healthcare system innovative infrastructure in...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.3228

    authors： Paxton EW,Ake CF,Inacio MC,Khatod M,Marinac-Dabic D,Sedrakyan A

    更新日期：2012-05-01 00:00:00

  • vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real-world use.

    abstract：PURPOSE:vigiRank is a data-driven predictive model for emerging safety signals. In addition to disproportionate reporting patterns, it also accounts for the completeness, recency, and geographic spread of individual case reporting, as well as the availability of case narratives. Previous retrospective analysis suggeste...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.4247

    authors： Caster O,Sandberg L,Bergvall T,Watson S,Norén GN

    更新日期：2017-08-01 00:00:00

  • The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results.

    abstract：:Purpose - The objective of this study was an evaluation of the sensitivity of findings of the relationship between oral corticosteroid use and the risk of fracture. We found in earlier work that the risk of fracture was significantly higher during oral corticosteroid treatment, with increases of 61% in hip and 160% in...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.

    authors： Van Staa TP,Abenhaim L,Cooper C,Zhang B,Leufkens HG

    更新日期：2000-09-01 00:00:00

  • Data sources on drug safety evaluation: a review of recent published meta-analyses.

    abstract：PURPOSE:Meta-analysis is a quantitative approach to summarize the findings from several studies and has been applied with increasing frequency to clinical trials. Because of their sample size and duration limitations, experimental studies (ESs) could not be able to detect late or rare adverse events (AEs), which may be...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章,评审

    doi：10.1002/pds.2260

    authors： Alves C,Batel-Marques F,Macedo AF

    更新日期：2012-01-01 00:00:00

  • Cluster randomized trials to study the comparative effectiveness of therapeutics: stakeholders' concerns and recommendations.

    abstract：PURPOSE:To describe the concerns raised by health plan members, providers and purchasers related to studying the comparative effectiveness of therapeutics using cluster randomized trials (CRTs) within health plans. An additional goal was to develop recommendations for increasing acceptability. METHODS:Eighty-four qual...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1754

    authors： Mazor KM,Sabin JE,Goff SL,Smith DH,Rolnick S,Roblin D,Raebel MA,Herrinton LJ,Gurwitz JH,Boudreau D,Meterko V,Dodd KS,Platt R

    更新日期：2009-07-01 00:00:00

  • Trends in antidepressant prescriptions for children and adolescents in Germany from 2005 to 2012.

    abstract：PURPOSE:Longitudinal data on prescriptions of antidepressants (AD) in children and adolescents depression are scarce. This study aimed to examine AD prescription trends in children and adolescents in Germany. METHODS:Data of a large statutory health insurance company were analyzed for the period 2005-2012, and outpati...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 历史文章,杂志文章

    doi：10.1002/pds.3649

    authors： Hoffmann F,Glaeske G,Bachmann CJ

    更新日期：2014-12-01 00:00:00

  • Incidence, risk factors, and outcomes of warfarin-associated major bleeding in Thai population.

    abstract：PURPOSE:This study aimed to describe incidence, risk factors, and outcomes of warfarin-associated major bleeding (WAMB) in Thai patients. METHOD:A nested case-control study was conducted in a cohort of adult patients receiving ≥6 months of warfarin therapy who were prospectively followed up at a tertiary care hospital...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.4781

    authors： Priksri W,Rattanavipanon W,Saejear W,Tanyasaensook K,Phrommintikul A,Chulavatnatol S,Nathisuwan S

    更新日期：2019-07-01 00:00:00

  • Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project.

    abstract：PURPOSE:In this proof-of-concept paper we describe the framework, process, and preliminary results of combining data from European electronic healthcare record (EHR) databases for large-scale monitoring of drug safety. METHODS:Aggregated demographic, clinical, and prescription data from eight databases in four countri...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.2053

    authors： Coloma PM,Schuemie MJ,Trifirò G,Gini R,Herings R,Hippisley-Cox J,Mazzaglia G,Giaquinto C,Corrao G,Pedersen L,van der Lei J,Sturkenboom M,EU-ADR Consortium.

    更新日期：2011-01-01 00:00:00

  • Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?

    abstract：:Before a medicine can be recommended for a marketing authorization research must be provided to regulators that convincingly supports the benefit-risk of the product in the claimed indication. The established criteria for such research are usually expressed in terms of evidence from randomized controlled trials (RCT)....

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.5005

    authors： Slattery J,Kurz X

    更新日期：2020-10-01 00:00:00

  • Validation of a coding algorithm for intra-abdominal surgeries and adhesion-related complications in an electronic medical records database.

    abstract：PURPOSE:Epidemiological data on adhesion-related complications following intra-abdominal surgery are limited. We tested the accuracy of recording of these surgeries and complications within The Health Improvement Network (THIN), a primary care database within the UK. METHODS:Individuals within THIN from 1995 to 2011 w...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.3974

    authors： Scott FI,Mamtani R,Haynes K,Goldberg DS,Mahmoud NN,Lewis JD

    更新日期：2016-04-01 00:00:00

  • Results from a 9-year Intensive Safety Surveillance Scheme (IS(3) ) in miglustat (Zavesca(®) )-treated patients.

    abstract：BACKGROUND:Following approval in the EU in 2002 and the USA in 2003, an Intensive Safety Surveillance Scheme (IS(3) ) was initiated to educate prescribers on the appropriate use of miglustat for the treatment of type I Gaucher disease (GD1), and to actively solicit safety-relevant information. This report summarises da...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章,多中心研究

    doi：10.1002/pds.3760

    authors： Brand M,Muller A,Alsop J,van Schaik IN,Bembi B,Hughes D

    更新日期：2015-03-01 00:00:00

  • Uses of proton pump inhibitors and serum potassium levels.

    abstract：PURPOSE:Proton pump inhibitor (PPI) may suppress adrenal cortical steroid synthesis and release, thereby leading to electrolyte disturbances. Both hyponatremia and hyperkalemia in the setting of PPI therapy have been documented in case reports. The objective of this study was to examine the association between serum po...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1795

    authors： Gau JT,Heh V,Acharya U,Yang YX,Kao TC

    更新日期：2009-09-01 00:00:00

  • Physician adherence to recommendations for duration of empiric antibiotic treatment for uncomplicated urinary tract infection in women: a national drug utilization analysis.

    abstract：BACKGROUND:Current guidelines for the empiric treatment of uncomplicated urinary tract infection in women recommend that first-line trimethoprim-sulfamethoxazole (TMP-SMX) or ofloxacin be given for 3 days and nitrofurantoin for 5 days. Increasing the duration of treatment raises costs, and perhaps, the incidence of adv...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.862

    authors： Kahan NR,Chinitz DP,Kahan E

    更新日期：2004-04-01 00:00:00

  • Confounding by indication: the case of calcium channel blockers.

    abstract：PURPOSE:To review conceptual issues regarding confounding by indication in the context of studies of calcium channel blockers (CCBs). METHODS:Review of literature, with special attention to two articles in the current issue. RESULTS:Conflicting arguments about the presence of uncontrollable confounding by indication ...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/(SICI)1099-1557(200001/02)9:1<37::AID-PDS4

    authors： Joffe MM

    更新日期：2000-01-01 00:00:00

  • A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications.

    abstract：PURPOSE:Stimulant medications used for treating attention deficit hyperactivity disorder (ADHD) can be associated with an increased risk of seizures. Atomoxetine is a non-stimulant medication approved for treating ADHD. This retrospective cohort analysis evaluated risk of seizures among pediatric patients naïve to ADHD...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.3390

    authors： McAfee AT,Landon J,Jones M,Bangs ME,Acharya N,Hornbuckle K,Wong J

    更新日期：2013-04-01 00:00:00

  • A ranked presentation of the MHRA/CSM (Medicines & Health Care Regulatory Agency/Committee on Safety of Medicines) Drug Analysis Print (DAP) data on practolol.

    abstract：PURPOSE:To display a ranked presentation of the data given in the Drug Analysis Prints (DAPs) provided by the MHRA/CSM so that the monitoring clinician may be readily alerted to the most important findings. The practolol DAP is taken as an example of the presentation. METHOD:The data for the ranked system organ classe...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1144

    authors： Mann RD

    更新日期：2005-10-01 00:00:00

  • Conducting pharmacoepidemiologic research in Denmark.

    abstract：:Denmark has one of the worlds most comprehensive registration of its citizens' use of medical and social services. Most databases are population-based and of very high quality. Virtually all employ a mutual person identifier, which renders it technically possible to link any of them with others. There are two prescrip...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.638

    authors： Hallas J

    更新日期：2001-12-01 00:00:00

  • Risk of local adverse events by gender following cardiac catheterization.

    abstract：PURPOSE:To assess the reason for the relative high risk of local complications for women following cardiac catheterization by evaluating the associations between gender, sheath size, and local adverse outcomes following cardiac catheterization. METHODS:The data used in this study were obtained from a portion of the Am...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章,多中心研究

    doi：10.1002/pds.1307

    authors： Tavris DR,Gallauresi BA,Dey S,Brindis R,Mitchel K

    更新日期：2007-02-01 00:00:00

  • The association between proton pump inhibitor use and the risk of tuberculosis: A case-control study.

    abstract：PURPOSE:Few studies have reported an association between proton pump inhibitor (PPI) use and tuberculosis. Tuberculosis incidence is relatively high in Asian people, and an increase in PPI prescriptions has been reported in South Korea. Thus, we investigated the association between PPI use and tuberculosis development....

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.4773

    authors： Song HJ,Park H,Park S,Kwon JW

    更新日期：2019-06-01 00:00:00

  • QUALYOP project 2: monitoring the dismantling of Italian psychiatric hospitals. Psychotropic drug use in 1072 inpatients.

    abstract：OBJECTIVE:This study describes the use of psychotropic drugs in a sample of eight Italian psychiatric hospitals. METHODS:A cross-sectional approach was used to collect information about sociodemographic and clinical characteristics of the inpatient population, and about medications prescribed. Prescribing behaviour in...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/(SICI)1099-1557(199908/09)8:5<331::AID-PDS

    authors： Barbui C,D'Avanzo B,Frattura L,Saraceno B

    更新日期：1999-08-01 00:00:00

  • Trends in the consumption of antidepressants in Castilla y León (Spain). Association between suicide rates and antidepressant drug consumption.

    abstract：OBJECTIVE:To learn the evolution of antidepressant and lithium use in Castilla y León (Central Spain) and its relationship with suicide rates. METHODS:A search in the ECOM (Especialidades Consumo de Medicamentos) database of the Spanish Ministry of Health for antidepressants and lithium was carried out for the period ...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1944

    authors： Arias LH,Lobato CT,Ortega S,Velasco A,Carvajal A,del Pozo JG

    更新日期：2010-09-01 00:00:00

  • Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder.

    abstract：OBJECTIVE:This study quantified the overall merit of adjunctive aripiprazole in major depressive disorder (MDD). METHODS:Global benefit-risk (GBR) analysis quantified the benefit and risk differences between adjunctive aripiprazole and antidepressant (ADT) monotherapy. Three hundred and fifty six patients receiving AD...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1805

    authors： Wisniewski SR,Chen CC,Kim E,Kan HJ,Guo Z,Carlson BX,Tran QV,Pikalov A

    更新日期：2009-10-01 00:00:00

  • Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study.

    abstract：PURPOSE:Warfarin is commonly used among patients who receive influenza, pneumococcal, and tetanus and diphtheria toxoid vaccines, and persons on warfarin therapy may also receive Hepatitis A vaccine. There has been concern that vaccinations could potentially alter coagulation parameters in patients on warfarin therapy....

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1386

    authors： Jackson ML,Nelson JC,Chen RT,Davis RL,Jackson LA,Vaccine Safety Datalink investigators.

    更新日期：2007-07-01 00:00:00

  • In utero opioid exposure and risk of infections in childhood: A multinational Nordic cohort study.

    abstract：PURPOSE:There is an increasing number of children with in utero exposure to opioids. Knowledge about opioid safety in pregnancy, particularly for outcomes later in childhood is scarce. It has been suggested that opioids can modulate immune system and increase the risk of infections. Our goal was to study the impact of ...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.5088

    authors： Mahic M,Hernandez-Diaz S,Wood M,Kieler H,Odsbu I,Nørgaard M,Öztürk B,Bateman BT,Hjellvik V,Skurtveit S,Handal M

    更新日期：2020-12-01 00:00:00

  • Patient focused drug surveillance of elderly patients in nursing homes.

    abstract：PURPOSE:To examine whether patient focused drug surveillance was associated with a higher quality of drug treatment at nursing homes. METHODS:An intervention study in four nursing homes in Sweden and four other nursing homes served as controls. At the intervention nursing homes physicians focused on patients' health s...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.1891

    authors： Olsson IN,Curman B,Engfeldt P

    更新日期：2010-02-01 00:00:00

  • Generating and confirming hypotheses.

    abstract：:Dr. Walker asserts that a hypothesis always can be tested using the same data source that generated the data if the test data are independent of the data generating the hypothesis. One way to do this is to use part of the totality of data to generate the hypothesis and the other to test the hypothesis. The validity of...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 评论,杂志文章

    doi：10.1002/pds.1928

    authors： Gould AL

    更新日期：2010-05-01 00:00:00

  • How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.

    abstract：:It is surprising to see how consumer Adverse Drug Reaction (ADR) reports have been continuously increasing for the last few years in Europe. This probably results from the influence of United States (US) market where the patients feels justified in telephoning the pharmaceutical companies directly with queries regardi...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.650

    authors： Fleuranceau-Morel P

    更新日期：2002-01-01 00:00:00

  • Use of a multi-state model in a claims database: illustration with methadone.

    abstract：PURPOSE:In pharmacoepidemiology, one of the main concerns is analysis of drug exposure time. However, in real-life settings, patient's behavior is complex and characterized by drug exposure dynamics. Multi-state models allow assessing the probabilities of various patterns, instead of just continuous use and/or disconti...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.3835

    authors： Boucherie Q,Pauly V,Frauger E,Thirion X,Pradel V,Micallef J

    更新日期：2015-09-01 00:00:00

  • Psychotropic drugs and risk of burn injury in individuals with mental illness: a 10-year population-based case-control study.

    abstract：PURPOSE:We aimed to investigate the association between psychotropic treatment and risk of burn injury in individuals with mental illness. METHODS:A nested case-control study was conducted by using the National Health Insurance Research Database in Taiwan. A total of 3187 cases with burn injury under International Cla...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章

    doi：10.1002/pds.3995

    authors： Chang CM,Wu KY,Chiu YW,Wu HT,Tsai YT,Chau YL,Tsai HJ

    更新日期：2016-08-01 00:00:00

  • Herbal products use during pregnancy: prevalence and predictors.

    abstract：PURPOSES:(1) Measure the prevalence of herbal product (HP) use, alone, and concomitantly with prescribed medications during pregnancy, (2) identify the most frequently consumed HP during gestation and (3) determine predictors of HP use at the beginning of pregnancy, and during the third trimester. METHODS:A questionna...

    journal_title：Pharmacoepidemiology and drug safety

    pub_type： 杂志文章,评审

    doi：10.1002/pds.1731

    authors： Moussally K,Oraichi D,Bérard A

    更新日期：2009-06-01 00:00:00